close
close

11-22-2024 | Phreesia has been named to The Software Report’s “Top 100 Software Companies” for the third year in a row NYSE:PHR

11-22-2024 | Phreesia has been named to The Software Report’s “Top 100 Software Companies” for the third year in a row NYSE:PHR

Phreesia, a leader in patient acquisition, outreach and activation, has been selected by The software report as one of the “Top 100 Software Companies of 2024.” The annual program evaluates companies based on a range of criteria, including product functionality, customer satisfaction, corporate reputation, innovative capabilities, organizational depth, ESG engagement and long-term viability. This is the third year in a row that Phreesia has been named to the list.

“We are proud to once again be recognized as a leader in SaaS innovation,” said Phreesia CEO Chaim Indig. “This honor reflects Phreesia&CloseCurlyQuote’s dedication to investing in products that help achieve better health outcomes. We are committed to making care easier every day and transforming the healthcare experience for both patients and providers.”

In the announcement, The software report describes its list of honored companies as those “having a major impact on the software industry” in 2024. Phreesia is ranked 11of the 100 companies, up four spots from 2023. Other honorees this year include Hootsuite, Celigo and Enable.

For more information on Phreesia, visit www.phreesia.com.

About Phreesia

Phreesia is the trusted leader in patient activation, providing providers, life sciences companies and other organizations with tools to help patients take a more active role in their care. Founded in 2005, Phreesia has enabled approximately 150 million patient visits in 2023 – more than 1 in 10 visits in the US – a scale we believe allows us to make a significant impact. By providing patient-centric digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, increases efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.